155 related articles for article (PubMed ID: 15684729)
1. Potential role of inhibitors of neutrophil elastase in treating diseases of the airway.
Chughtai B; O'Riordan TG
J Aerosol Med; 2004; 17(4):289-98. PubMed ID: 15684729
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
Bingle L; Tetley TD
Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor.
Suzuki T; Wang W; Lin JT; Shirato K; Mitsuhashi H; Inoue H
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1405-11. PubMed ID: 8616573
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
5. [Elastase inhibitors].
Reboud-Ravaux M
J Soc Biol; 2001; 195(2):143-50. PubMed ID: 11723826
[TBL] [Abstract][Full Text] [Related]
6. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
7. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of lung diseases with antiproteases].
Vogelmeier C; Buhl R
Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
[TBL] [Abstract][Full Text] [Related]
9. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
Vogelmeier C; Gillissen A; Buhl R
Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 - 2014).
Tsai YF; Hwang TL
Expert Opin Ther Pat; 2015; 25(10):1145-58. PubMed ID: 26118988
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
Rees DD; Rogers RA; Cooley J; Mandle RJ; Kenney DM; Remold-O'Donnell E
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):69-78. PubMed ID: 9870919
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease.
Reid PT; Sallenave JM
Curr Opin Investig Drugs; 2001 Jan; 2(1):59-67. PubMed ID: 11527014
[TBL] [Abstract][Full Text] [Related]
13. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
[TBL] [Abstract][Full Text] [Related]
14. The potential role of elastase inhibitors in emphysema treatment.
Eriksson S
Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
[TBL] [Abstract][Full Text] [Related]
17. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
Belorgey D; Bieth JG
Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
[TBL] [Abstract][Full Text] [Related]
18. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFalpha) and activated neutrophils in isolated perfused rabbit lungs.
Miyazaki Y; Inoue T; Kyi M; Sawada M; Miyake S; Yoshizawa Y
Am J Respir Crit Care Med; 1998 Jan; 157(1):89-94. PubMed ID: 9445283
[TBL] [Abstract][Full Text] [Related]
19. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
20. The Role of Neutrophil Elastase Inhibitors in Lung Diseases.
Polverino E; Rosales-Mayor E; Dale GE; Dembowsky K; Torres A
Chest; 2017 Aug; 152(2):249-262. PubMed ID: 28442313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
